FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk

Follow Drugslib on

By Stephanie Brown HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 3, 2025.

via HealthDay

WEDNESDAY, July 2, 2025 -- The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity disorder (ADHD) medications, including certain formulations of amphetamine and methylphenidate, to warn about the medication's risk for weight loss and other adverse reactions in patients younger than 6 years of age.

Extended-release stimulants are currently not approved for children younger than 6 years, but health care professionals do prescribe them "off label" to treat ADHD.

Clinical trials have shown that compared with older children, patients younger than 6 years have higher levels of the drug in their bodies and higher rates of side effects. Children younger than 6 years can also suffer clinically significant weight loss.

The FDA is requiring a Limitation of Use section be added to the prescribing information of all extended-release stimulants. This section will include a statement about the higher plasma exposures and higher rates of adverse reactions observed in children younger than 6 years.

For children taking an extended-release stimulant, health care providers should regularly chart the patient's growth and development, be aware that interventions may be needed to address and mitigate any weight loss, and consider prescribing other ADHD medications, such as immediate-release stimulants, or recommend behavioral therapies.

If parents or caregivers observe weight loss in their child who is taking an extended-release stimulant, they should contact their pediatrician or another health care provider to review the benefits and harms of continuing treatment.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-03 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords